• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Intermediate risk prostate cancer: disease heterogeneity linked to measurable biological features

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    32147317.pdf
    Size:
    385.6Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Rebello, Richard
    Bristow, Robert G
    Affiliation
    Translational Oncogenomics Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre, Manchester
    Issue Date
    2020
    
    Metadata
    Show full item record
    Citation
    Rebello RJ, Bristow RG. Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features. Clin Oncol (R Coll Radiol). 2020.
    Journal
    Clinical Oncology
    URI
    http://hdl.handle.net/10541/622864
    DOI
    10.1016/j.clon.2019.11.002
    PubMed ID
    32147317
    Additional Links
    https://dx.doi.org/10.1016/j.clon.2019.11.002
    Type
    Meetings and Proceedings
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.clon.2019.11.002
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Active surveillance in intermediate risk prostate cancer.
    • Authors: Chandrasekar T, Herrera-Caceres JO, Klotz L
    • Issue date: 2019 Mar
    • Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.
    • Authors: Yang DD, Muralidhar V, Nguyen PL, Buzurovic I, Martin NE, Mouw KW, Devlin PM, Trinh QD, Orio PF 3rd, King MT
    • Issue date: 2017 Nov 15
    • Active surveillance in intermediate-risk prostate cancer.
    • Authors: Klotz L
    • Issue date: 2020 Mar
    • Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer Patients after Radical Prostatectomy: Influence of Primary and Secondary Gleason Score.
    • Authors: Pollard ME, Hobbs AR, Kwon YS, Katsigeorgis M, Lavery HJ, Levinson A, Bernstein AN, Collingwood SA, Hall SJ, Jazayeri SB, Samadi DB
    • Issue date: 2017
    • Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
    • Authors: Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D
    • Issue date: 2005 Mar 15
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.